FibroBiologics Announces Three United States Patents for Fibroblast Technology
/PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and...
Stay updated with breaking news from Harrison Seidner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and...
HOUSTON, Feb. 6, 2024 /PRNewswire/ -- FibroBiologics , a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts...
/PRNewswire/ -- FibroBiologics, Inc. ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures...
SEATTLE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ('BWB' or the “Company”) today announced the acquisition of...